This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ADMANegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Freightcar America (RAIL) Surges 5.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
Freightcar America (RAIL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
RAILPositive Net Change RNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Aeva Technologies (AEVA) Soars 9.5%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Aeva Technologies (AEVA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
AEVAPositive Net Change OSKNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
TrueBlue (TBI) Soars 5.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
TrueBlue (TBI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
TBIPositive Net Change RGPNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
Catalyst (CPRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
CPRXPositive Net Change IRWDPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Genius Sports Limited (GENI) Moves 6.1% Higher: Will This Strength Last?
by Zacks Equity Research
Genius Sports Limited (GENI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
GENIPositive Net Change DHXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
M-tron Industries, Inc. (MPTI) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
MPTIPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
JD.com, Inc. (JD) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
JDNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Oddity Tech (ODD) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
ODDNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
AnaptysBio (ANAB) Moves 9.5% Higher: Will This Strength Last?
by Zacks Equity Research
AnaptysBio (ANAB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
ANABPositive Net Change MGTXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Vitesse (VTS) Stock Jumps 7.1%: Will It Continue to Soar?
by Zacks Equity Research
Vitesse (VTS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
VTSPositive Net Change REPXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Valmont (VMI) Moves 4.7% Higher: Will This Strength Last?
by Zacks Equity Research
Valmont (VMI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
VMINegative Net Change TSNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Central Garden (CENT) Surges 5.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
Central Garden (CENT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CENTNegative Net Change REALPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Guild (GHLD) Moves 5.2% Higher: Will This Strength Last?
by Zacks Equity Research
Guild (GHLD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
GHLDPositive Net Change CORZNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Cytokinetics (CYTK) Moves 5.4% Higher: Will This Strength Last?
by Zacks Equity Research
Cytokinetics (CYTK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CYTKNegative Net Change CLDXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Porch Group (PRCH) Surges 6.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Porch Group (PRCH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
PRCHPositive Net Change BRZENegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Amtech (ASYS) Stock Jumps 5.5%: Will It Continue to Soar?
by Zacks Equity Research
Amtech (ASYS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ASYSPositive Net Change STMPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Mistras (MG) Surges 5.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
Mistras (MG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
MGPositive Net Change UEICNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Alnylam (ALNY) Surges 11.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
Alnylam (ALNY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
ALNYPositive Net Change DNTHPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Should You Buy ANI Pharmaceuticals (ANIP) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ANIPPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Hims & Hers Health (HIMS) Moves 5.7% Higher: Will This Strength Last?
by Zacks Equity Research
Hims & Hers Health (HIMS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
HIMSPositive Net Change FLGTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Immunocore (IMCR) Moves 6.0% Higher: Will This Strength Last?
by Zacks Equity Research
Immunocore (IMCR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
IMCRPositive Net Change FENCPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
SoundThinking (SSTI) Surges 6.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
SoundThinking (SSTI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
SSTINegative Net Change ALRMNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in ProAssurance (PRA): Can Its 48.1% Jump Turn into More Strength?
by Zacks Equity Research
ProAssurance (PRA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
PRAPositive Net Change CNAPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in International General Insurance (IGIC): Can Its 5.4% Jump Turn into More Strength?
by Zacks Equity Research
International General Insurance (IGIC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
IGICPositive Net Change ORIPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today